Clinicopathological characteristics and survival outcomes of bladder neuroendocrine carcinomas: a population-based study
Quan Niu,1,* Youyi Lu,2,* Shigao Xu,3 Qun Shi,3 Baoyu Guo,1 Zhe Guo,1 Tianbao Huang,3 Yinxia Wu,4 Junjie Yu3 1Department of Dalian Medical University, Dalian, Liaoning, People’s Republic of China; 2Department of Urology, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yan...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2018-10-01
|
| Series: | Cancer Management and Research |
| Subjects: | |
| Online Access: | https://www.dovepress.com/clinicopathological-characteristics-and-survival-outcomes-of-bladder-n-peer-reviewed-article-CMAR |
| _version_ | 1818160171489165312 |
|---|---|
| author | Niu Q Lu Y Xu S Shi Q Guo B Guo Z Huang T Wu Y Yu J |
| author_facet | Niu Q Lu Y Xu S Shi Q Guo B Guo Z Huang T Wu Y Yu J |
| author_sort | Niu Q |
| collection | DOAJ |
| description | Quan Niu,1,* Youyi Lu,2,* Shigao Xu,3 Qun Shi,3 Baoyu Guo,1 Zhe Guo,1 Tianbao Huang,3 Yinxia Wu,4 Junjie Yu3 1Department of Dalian Medical University, Dalian, Liaoning, People’s Republic of China; 2Department of Urology, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, Shandong, People’s Republic of China; 3Department of Urology, Subei People’s Hospital of Jiangsu Province (Clinical Medical College, Yangzhou University), Yangzhou, Jiangsu, People’s Republic of China; 4Department of Oncology, Subei People’s Hospital of Jiangsu Province (Clinical Medical College, Yangzhou University), Yangzhou, Jiangsu, People’s Republic of China *These authors contributed equally to this work Background: Bladder neuroendocrine carcinomas (BNECs) are relatively a rare type of tumor. The aim of this study was to examine the clinicopathological characteristics and predictors of survival outcomes of patients with BNECs based on the analysis of the national Surveillance, Epidemiology, and End Results (SEER) database. Materials and methods: Kaplan–Meier analysis with log-rank test was used for survival comparisons. Multivariate Cox regression model was employed to analyze the effect of different treatments on overall survival (OS) and cancer-specific survival (CSS). Results: A total of 910 patients were identified between 2004 and 2014. Overall, 648 (71.2%) patients had small cell neuroendocrine carcinoma (SCNEC), 35 (3.8%) had large cell neuroendocrine carcinoma (LCNEC), 10 (1.1%) had carcinoid tumor (well-differentiated neuroendocrine tumor), 16 (1.8%) had paraganglioma/pheochromocytoma (PGL/PHEO), 619 (68.0%) had a poorly differentiated or undifferentiated histology grade, 214 (23.5%) presented with metastatic disease, 586 (64.4%) underwent transurethral ablation/destruction for bladder tumor, and 245 (26.9%) had partial/total cystectomy. Cystectomy+chemotherapy+radiotherapy (CCR) has the highest long-term survival rate among various treatments. The 1-, 3-, and 5-years CSS of CCR were 56%, 56%, and 56%, respectively. By using multivariable Cox proportional hazard model, age, histology, N stage, SEER stage, tumor size, radiotherapy, chemotherapy, and local treatment of the primary site were identified as independent predictors for OS and CSS; all P<0.05. Conclusion: In BNEC, SCNEC has an absolute advantage in number. SCNEC/LCNEC tend to be older men. PGL/PHEO and carcinoid tumors have younger mean ages, earlier tumor stages, and better prognosis than SCNEC/LCNEC. Surgery, radiotherapy and chemotherapy are better than conservative treatment. However, whatever cystectomy or bladder sparing, chemotherapy should be a major component of treatment. Keywords: bladder neuroendocrine carcinomas, clinicopathological characteristics, prognosis, treatment, Surveillance, Epidemiology, and End Results |
| first_indexed | 2024-12-11T15:57:38Z |
| format | Article |
| id | doaj.art-9a581976bcff4f56b6aea9420b7cc5b3 |
| institution | Directory Open Access Journal |
| issn | 1179-1322 |
| language | English |
| last_indexed | 2024-12-11T15:57:38Z |
| publishDate | 2018-10-01 |
| publisher | Dove Medical Press |
| record_format | Article |
| series | Cancer Management and Research |
| spelling | doaj.art-9a581976bcff4f56b6aea9420b7cc5b32022-12-22T00:59:22ZengDove Medical PressCancer Management and Research1179-13222018-10-01Volume 104479448941393Clinicopathological characteristics and survival outcomes of bladder neuroendocrine carcinomas: a population-based studyNiu QLu YXu SShi QGuo BGuo ZHuang TWu YYu JQuan Niu,1,* Youyi Lu,2,* Shigao Xu,3 Qun Shi,3 Baoyu Guo,1 Zhe Guo,1 Tianbao Huang,3 Yinxia Wu,4 Junjie Yu3 1Department of Dalian Medical University, Dalian, Liaoning, People’s Republic of China; 2Department of Urology, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, Shandong, People’s Republic of China; 3Department of Urology, Subei People’s Hospital of Jiangsu Province (Clinical Medical College, Yangzhou University), Yangzhou, Jiangsu, People’s Republic of China; 4Department of Oncology, Subei People’s Hospital of Jiangsu Province (Clinical Medical College, Yangzhou University), Yangzhou, Jiangsu, People’s Republic of China *These authors contributed equally to this work Background: Bladder neuroendocrine carcinomas (BNECs) are relatively a rare type of tumor. The aim of this study was to examine the clinicopathological characteristics and predictors of survival outcomes of patients with BNECs based on the analysis of the national Surveillance, Epidemiology, and End Results (SEER) database. Materials and methods: Kaplan–Meier analysis with log-rank test was used for survival comparisons. Multivariate Cox regression model was employed to analyze the effect of different treatments on overall survival (OS) and cancer-specific survival (CSS). Results: A total of 910 patients were identified between 2004 and 2014. Overall, 648 (71.2%) patients had small cell neuroendocrine carcinoma (SCNEC), 35 (3.8%) had large cell neuroendocrine carcinoma (LCNEC), 10 (1.1%) had carcinoid tumor (well-differentiated neuroendocrine tumor), 16 (1.8%) had paraganglioma/pheochromocytoma (PGL/PHEO), 619 (68.0%) had a poorly differentiated or undifferentiated histology grade, 214 (23.5%) presented with metastatic disease, 586 (64.4%) underwent transurethral ablation/destruction for bladder tumor, and 245 (26.9%) had partial/total cystectomy. Cystectomy+chemotherapy+radiotherapy (CCR) has the highest long-term survival rate among various treatments. The 1-, 3-, and 5-years CSS of CCR were 56%, 56%, and 56%, respectively. By using multivariable Cox proportional hazard model, age, histology, N stage, SEER stage, tumor size, radiotherapy, chemotherapy, and local treatment of the primary site were identified as independent predictors for OS and CSS; all P<0.05. Conclusion: In BNEC, SCNEC has an absolute advantage in number. SCNEC/LCNEC tend to be older men. PGL/PHEO and carcinoid tumors have younger mean ages, earlier tumor stages, and better prognosis than SCNEC/LCNEC. Surgery, radiotherapy and chemotherapy are better than conservative treatment. However, whatever cystectomy or bladder sparing, chemotherapy should be a major component of treatment. Keywords: bladder neuroendocrine carcinomas, clinicopathological characteristics, prognosis, treatment, Surveillance, Epidemiology, and End Resultshttps://www.dovepress.com/clinicopathological-characteristics-and-survival-outcomes-of-bladder-n-peer-reviewed-article-CMARbladder neuroendocrine carcinomasclinicopathological characteristicsprognosistreatmentSurveillanceEpidemiology and End Results |
| spellingShingle | Niu Q Lu Y Xu S Shi Q Guo B Guo Z Huang T Wu Y Yu J Clinicopathological characteristics and survival outcomes of bladder neuroendocrine carcinomas: a population-based study Cancer Management and Research bladder neuroendocrine carcinomas clinicopathological characteristics prognosis treatment Surveillance Epidemiology and End Results |
| title | Clinicopathological characteristics and survival outcomes of bladder neuroendocrine carcinomas: a population-based study |
| title_full | Clinicopathological characteristics and survival outcomes of bladder neuroendocrine carcinomas: a population-based study |
| title_fullStr | Clinicopathological characteristics and survival outcomes of bladder neuroendocrine carcinomas: a population-based study |
| title_full_unstemmed | Clinicopathological characteristics and survival outcomes of bladder neuroendocrine carcinomas: a population-based study |
| title_short | Clinicopathological characteristics and survival outcomes of bladder neuroendocrine carcinomas: a population-based study |
| title_sort | clinicopathological characteristics and survival outcomes of bladder neuroendocrine carcinomas a population based study |
| topic | bladder neuroendocrine carcinomas clinicopathological characteristics prognosis treatment Surveillance Epidemiology and End Results |
| url | https://www.dovepress.com/clinicopathological-characteristics-and-survival-outcomes-of-bladder-n-peer-reviewed-article-CMAR |
| work_keys_str_mv | AT niuq clinicopathologicalcharacteristicsandsurvivaloutcomesofbladderneuroendocrinecarcinomasapopulationbasedstudy AT luy clinicopathologicalcharacteristicsandsurvivaloutcomesofbladderneuroendocrinecarcinomasapopulationbasedstudy AT xus clinicopathologicalcharacteristicsandsurvivaloutcomesofbladderneuroendocrinecarcinomasapopulationbasedstudy AT shiq clinicopathologicalcharacteristicsandsurvivaloutcomesofbladderneuroendocrinecarcinomasapopulationbasedstudy AT guob clinicopathologicalcharacteristicsandsurvivaloutcomesofbladderneuroendocrinecarcinomasapopulationbasedstudy AT guoz clinicopathologicalcharacteristicsandsurvivaloutcomesofbladderneuroendocrinecarcinomasapopulationbasedstudy AT huangt clinicopathologicalcharacteristicsandsurvivaloutcomesofbladderneuroendocrinecarcinomasapopulationbasedstudy AT wuy clinicopathologicalcharacteristicsandsurvivaloutcomesofbladderneuroendocrinecarcinomasapopulationbasedstudy AT yuj clinicopathologicalcharacteristicsandsurvivaloutcomesofbladderneuroendocrinecarcinomasapopulationbasedstudy |